• Image

You are here » Focus on the Skin » Skin Cancer » References



  1. Ackerman AB and Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006;155(1):9-22.
  2. American Cancer Society. Skin Cancer monograph. 2007.
  3. Balch CM et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19(16):3635-48.
  4. Balch CM, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009 20;27(36):6199-206.
  5. Braathen LR et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56(1):125-43.
  6. Cerroni L. Mycosis fungoides. Orphanet Encyclopedia. October 2003.
  7. Cornish D et al. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009;20 Suppl 6:vi51-8.
  8. Cox NH et al. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 2007;156(1):11-21.
  9. Curtin JA et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353(20):2135-47.
  10. Eggermont AM, et al. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet 2008;372(9633):117-26.
  11. Erb P et al. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. In: Reichrath J, eds. Sunlight, Vitamin D, and Skin Cancer.New York, NY: Springer; 2008:283-295.
  12. Flaherty KT et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010;363(9):809-19.
  13. Gachon J, et al. First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol 2005;141(4):434-8.
  14. Gloster HM Jr and Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22(3):217-26.
  15. Hersey P et al. Small molecules and targeted therapies in distant metastatic disease. Ann Oncol 2009;20 Suppl 6:vi35-40.
  16. Hodi FS et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363(8):711-23.
  17. Keehn CA et al. The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control 2007;14(2):102-11.
  18. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007;156(5):793-801.
  19. Leiter U and Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol 2008;624:89-103.
  20. MacKie RM et al. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009;20 Suppl 6:vi1-7.
  21. Meyle KD and Guldberg P. Genetic risk factors for melanoma. Hum Genet 2009;126(4):499-510.
  22. Ming M and He YY. PTEN: new insights into its regulation and function in skin cancer. J Invest Dermatol 2009;129(9):2109-12.
  23. Motley R, et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002 Jan;146(1):18-25.
  24. NCCN Clinical Practice Guidelines in Oncology. Basal Cell and Squamous Cell Skin Cancers. 2007.
  25. NCCN Clinical Practice Guidelines in Oncology. Melanoma. 2008.
  26. Neubert T and Lehmann P. Bowen's disease - a review of newer treatment options. Ther Clin Risk Manag 2008;4(5):1085-95.
  27. Olsen E et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110(6):1713-22.
  28. Parkin DM et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108.
  29. Quatresooz P et al. Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. Eur J Dermatol 2008;18(1):6-10.
  30. Rass K and Reichrath J. UV damage and DNA repair in melanoma and nonmelanoma skin cancer. In: Reichrath J, eds. Sunlight, Vitamin D, and Skin Cancer. New York, NY: Springer; 2008:163-178.
  31. Stasko T et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004;30(4 Pt 2):642-50.
  32. Stockfleth E et al. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006;16(6):599-606.
  33. Strayer SM and Reynolds PL. Diagnosing skin malignancy: assessment of predictive clinical criteria and risk factors. J Fam Pract 2003;52(3):210-8.
  34. Telfer NR, et al. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159(1):35-48.
  35. World Health Organization. Solar Ultraviolet Radiation: Global burden of disease from solar ultraviolet radiation. Environmental Burden of Disease Series, No. 13. 2006:1-250.

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world



We are committed

See all videos